CATALENT PHARMA SOLUTIONS INC SR GLBL 144A 29's ticker is and the CUSIP is 14879EAH1. A total of 1 filers reported holding CATALENT PHARMA SOLUTIONS INC SR GLBL 144A 29 in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $65,809 | -46.0% | 69,000 | -46.1% | 0.00% | – |
| Q1 2024 | $121,936 | +8.7% | 128,000 | 0.0% | 0.00% | – |
| Q4 2023 | $112,160 | +6.4% | 128,000 | 0.0% | 0.00% | – |
| Q3 2023 | $105,427 | +1.5% | 128,000 | 0.0% | 0.00% | – |
| Q2 2023 | $103,863 | -27.9% | 128,000 | -26.9% | 0.00% | -100.0% |
| Q2 2022 | $144,000 | – | 175,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pacer Advisors, Inc. | 128,000 | $103,863 | 0.00% |